Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Benign Hematology
•
Thalassemia
What could explain failure to luspatercept in patients with transfusion-dependent beta thalassemia?
Related Questions
For pregnant nontransfusion dependent beta thalassemia patients, when would you consider ESAs for worsening anemia?
Is there specific data on using luspatercept for sickle beta+ thalassemia with transfusion-dependent anemia?
In a pregnant patient with PNH without aplastic anemia who has residual hemolysis while on ravulizumab and on prophylactic LMWH, what else can be done to reduce thrombotic risk and improve maternofetal outcomes?
Would you consider a positive DAT and indirect Coombs test, persistent and consistent with IgG warm antibody, clinically significant in absence of hemolysis?
What is your goal ferritin level in pregnancy?
Is there benefit to aggressively treating hemochromatosis in a patient who has already progressed to cirrhosis at the time of diagnosis?
What hydroxyurea dose do you target for HbSC disease?
How do you counsel patients with minimally symptomatic factor VII deficiency about procedures and periprocedural management?
How would you manage iron overload in sickle cell patients with cirrhosis?
Can lupus anticoagulant be positive despite a normal aPTT?
